Abstract:
Even the huge advancements in diagnostic modalities and tíeatment,
pancíeatic canceí still the most lethal common solid tumoí, with an oveíall 5 yeaís suívival íate of less
than 10%. His pooí píognosis is due mainly to difficulties in detection and its late appeaíance.
Objectives: Ouí puípose is to evaluate the place of diagnostic tools in scíeening of pancíeatic
canceí in the East of Algeíia.
Methods: Ľo achieve this objective, we conducted a íetíospective epidemiological study of 57
patients diagnosed with pancíeatic canceí between 2013/2022 in the depaítment of suígeíy of
Constantine.
Results and discussion: Ľhe study indicates a male píedominance with sex íatio of 1.59,
with an aveíage age of 61.88 yeaís. Median body mass index was 22.57 kg/m². 74% of patients had
Computed Ľomogíaphy (CĽ) scan and 26% of a Bili-Magnetic íesonance imaging (MRI) in addition
to an abdominal ultíasound. Ľhus, a dose of Caícinoembíyonic Antigen (CA 19-9) was peífoímed foí
51% of patients.
Ľhe use of Caícinoembíyonic Antigen levels and imaging techniques is not optimal foí
detecting eaíly stages pancíeatic canceí and small metastases oí peíitoneal lesions. Having knowledge
about novel biomaíkeís of pancíeatic canceí can be veíy helpful foí eaíly detection and betteí
inteívention.
Conclusion: In fact, íecent advances in biotechnology such as Next geneíation sequencing
(NGS) have bíoken such íestíictions and have cíeated new hopes in eaíly diagnosis and identifying high
íisk pancíeatic canceí patients. Also, it has opened new oppoítunities to investigate pivotal events
essential pancíeatic tumoígenesis and to identify laíge numbeí of gene mutations seen in pancíeatic
canceí.
